Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
UBR Quote, Financials, Valuation and Earnings
Last price:
$19.85
Seasonality move
:
2.15%
Day range:
$19.59 - $19.86
52-week range:
$13.69 - $25.83
Dividend yield:
4.87%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
2.3K
Avg. volume:
2.4K
1-year change:
-13.26%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
UBR
ProShares Ultra MSCI Brazil Capped
|
-- | -- | -- | -- | -- |
|
BRZU
Direxion Daily MSCI Brazil Bull 2X Shares
|
-- | -- | -- | -- | -- |
|
EZJ
ProShares Ultra MSCI Japan
|
-- | -- | -- | -- | -- |
|
PILL
Direxion Daily Pharmaceutical & Medical Bl 3X Shs
|
-- | -- | -- | -- | -- |
|
UGE
ProShares Ultra Consumer Staples
|
-- | -- | -- | -- | -- |
|
UPV
ProShares Ultra FTSE Europe
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
UBR
ProShares Ultra MSCI Brazil Capped
|
$19.86 | -- | -- | -- | $0.16 | 4.87% | -- |
|
BRZU
Direxion Daily MSCI Brazil Bull 2X Shares
|
$60.02 | -- | -- | -- | $0.77 | 4.49% | -- |
|
EZJ
ProShares Ultra MSCI Japan
|
$40.67 | -- | -- | -- | $0.18 | 1.71% | -- |
|
PILL
Direxion Daily Pharmaceutical & Medical Bl 3X Shs
|
$5.94 | -- | -- | -- | $0.02 | 1.42% | -- |
|
UGE
ProShares Ultra Consumer Staples
|
$18.54 | -- | -- | -- | $0.12 | 1.88% | -- |
|
UPV
ProShares Ultra FTSE Europe
|
$78.65 | -- | -- | -- | $0.34 | 1.79% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
UBR
ProShares Ultra MSCI Brazil Capped
|
-- | 0.270 | -- | -- |
|
BRZU
Direxion Daily MSCI Brazil Bull 2X Shares
|
-- | 0.270 | -- | -- |
|
EZJ
ProShares Ultra MSCI Japan
|
-- | 0.696 | -- | -- |
|
PILL
Direxion Daily Pharmaceutical & Medical Bl 3X Shs
|
-- | 0.921 | -- | -- |
|
UGE
ProShares Ultra Consumer Staples
|
-- | 0.634 | -- | -- |
|
UPV
ProShares Ultra FTSE Europe
|
-- | 0.632 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
UBR
ProShares Ultra MSCI Brazil Capped
|
-- | -- | -- | -- | -- | -- |
|
BRZU
Direxion Daily MSCI Brazil Bull 2X Shares
|
-- | -- | -- | -- | -- | -- |
|
EZJ
ProShares Ultra MSCI Japan
|
-- | -- | -- | -- | -- | -- |
|
PILL
Direxion Daily Pharmaceutical & Medical Bl 3X Shs
|
-- | -- | -- | -- | -- | -- |
|
UGE
ProShares Ultra Consumer Staples
|
-- | -- | -- | -- | -- | -- |
|
UPV
ProShares Ultra FTSE Europe
|
-- | -- | -- | -- | -- | -- |
ProShares Ultra MSCI Brazil Capped vs. Competitors
-
Which has Higher Returns UBR or BRZU?
Direxion Daily MSCI Brazil Bull 2X Shares has a net margin of -- compared to ProShares Ultra MSCI Brazil Capped's net margin of --. ProShares Ultra MSCI Brazil Capped's return on equity of -- beat Direxion Daily MSCI Brazil Bull 2X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UBRProShares Ultra MSCI Brazil Capped-- -- -- BRZUDirexion Daily MSCI Brazil Bull 2X Shares-- -- -- -
What do Analysts Say About UBR or BRZU?
ProShares Ultra MSCI Brazil Capped has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily MSCI Brazil Bull 2X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra MSCI Brazil Capped has higher upside potential than Direxion Daily MSCI Brazil Bull 2X Shares, analysts believe ProShares Ultra MSCI Brazil Capped is more attractive than Direxion Daily MSCI Brazil Bull 2X Shares.
Company Buy Ratings Hold Ratings Sell Ratings UBRProShares Ultra MSCI Brazil Capped0 0 0 BRZUDirexion Daily MSCI Brazil Bull 2X Shares0 0 0 -
Is UBR or BRZU More Risky?
ProShares Ultra MSCI Brazil Capped has a beta of 1.704, which suggesting that the stock is 70.366% more volatile than S&P 500. In comparison Direxion Daily MSCI Brazil Bull 2X Shares has a beta of 1.712, suggesting its more volatile than the S&P 500 by 71.182%.
-
Which is a Better Dividend Stock UBR or BRZU?
ProShares Ultra MSCI Brazil Capped has a quarterly dividend of $0.16 per share corresponding to a yield of 4.87%. Direxion Daily MSCI Brazil Bull 2X Shares offers a yield of 4.49% to investors and pays a quarterly dividend of $0.77 per share. ProShares Ultra MSCI Brazil Capped pays -- of its earnings as a dividend. Direxion Daily MSCI Brazil Bull 2X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UBR or BRZU?
ProShares Ultra MSCI Brazil Capped quarterly revenues are --, which are smaller than Direxion Daily MSCI Brazil Bull 2X Shares quarterly revenues of --. ProShares Ultra MSCI Brazil Capped's net income of -- is lower than Direxion Daily MSCI Brazil Bull 2X Shares's net income of --. Notably, ProShares Ultra MSCI Brazil Capped's price-to-earnings ratio is -- while Direxion Daily MSCI Brazil Bull 2X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra MSCI Brazil Capped is -- versus -- for Direxion Daily MSCI Brazil Bull 2X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UBRProShares Ultra MSCI Brazil Capped-- -- -- -- BRZUDirexion Daily MSCI Brazil Bull 2X Shares-- -- -- --
-
Which has Higher Returns UBR or EZJ?
ProShares Ultra MSCI Japan has a net margin of -- compared to ProShares Ultra MSCI Brazil Capped's net margin of --. ProShares Ultra MSCI Brazil Capped's return on equity of -- beat ProShares Ultra MSCI Japan's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UBRProShares Ultra MSCI Brazil Capped-- -- -- EZJProShares Ultra MSCI Japan-- -- -- -
What do Analysts Say About UBR or EZJ?
ProShares Ultra MSCI Brazil Capped has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra MSCI Japan has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra MSCI Brazil Capped has higher upside potential than ProShares Ultra MSCI Japan, analysts believe ProShares Ultra MSCI Brazil Capped is more attractive than ProShares Ultra MSCI Japan.
Company Buy Ratings Hold Ratings Sell Ratings UBRProShares Ultra MSCI Brazil Capped0 0 0 EZJProShares Ultra MSCI Japan0 0 0 -
Is UBR or EZJ More Risky?
ProShares Ultra MSCI Brazil Capped has a beta of 1.704, which suggesting that the stock is 70.366% more volatile than S&P 500. In comparison ProShares Ultra MSCI Japan has a beta of 1.322, suggesting its more volatile than the S&P 500 by 32.248%.
-
Which is a Better Dividend Stock UBR or EZJ?
ProShares Ultra MSCI Brazil Capped has a quarterly dividend of $0.16 per share corresponding to a yield of 4.87%. ProShares Ultra MSCI Japan offers a yield of 1.71% to investors and pays a quarterly dividend of $0.18 per share. ProShares Ultra MSCI Brazil Capped pays -- of its earnings as a dividend. ProShares Ultra MSCI Japan pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UBR or EZJ?
ProShares Ultra MSCI Brazil Capped quarterly revenues are --, which are smaller than ProShares Ultra MSCI Japan quarterly revenues of --. ProShares Ultra MSCI Brazil Capped's net income of -- is lower than ProShares Ultra MSCI Japan's net income of --. Notably, ProShares Ultra MSCI Brazil Capped's price-to-earnings ratio is -- while ProShares Ultra MSCI Japan's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra MSCI Brazil Capped is -- versus -- for ProShares Ultra MSCI Japan. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UBRProShares Ultra MSCI Brazil Capped-- -- -- -- EZJProShares Ultra MSCI Japan-- -- -- --
-
Which has Higher Returns UBR or PILL?
Direxion Daily Pharmaceutical & Medical Bl 3X Shs has a net margin of -- compared to ProShares Ultra MSCI Brazil Capped's net margin of --. ProShares Ultra MSCI Brazil Capped's return on equity of -- beat Direxion Daily Pharmaceutical & Medical Bl 3X Shs's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UBRProShares Ultra MSCI Brazil Capped-- -- -- PILLDirexion Daily Pharmaceutical & Medical Bl 3X Shs-- -- -- -
What do Analysts Say About UBR or PILL?
ProShares Ultra MSCI Brazil Capped has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Pharmaceutical & Medical Bl 3X Shs has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra MSCI Brazil Capped has higher upside potential than Direxion Daily Pharmaceutical & Medical Bl 3X Shs, analysts believe ProShares Ultra MSCI Brazil Capped is more attractive than Direxion Daily Pharmaceutical & Medical Bl 3X Shs.
Company Buy Ratings Hold Ratings Sell Ratings UBRProShares Ultra MSCI Brazil Capped0 0 0 PILLDirexion Daily Pharmaceutical & Medical Bl 3X Shs0 0 0 -
Is UBR or PILL More Risky?
ProShares Ultra MSCI Brazil Capped has a beta of 1.704, which suggesting that the stock is 70.366% more volatile than S&P 500. In comparison Direxion Daily Pharmaceutical & Medical Bl 3X Shs has a beta of 1.717, suggesting its more volatile than the S&P 500 by 71.662%.
-
Which is a Better Dividend Stock UBR or PILL?
ProShares Ultra MSCI Brazil Capped has a quarterly dividend of $0.16 per share corresponding to a yield of 4.87%. Direxion Daily Pharmaceutical & Medical Bl 3X Shs offers a yield of 1.42% to investors and pays a quarterly dividend of $0.02 per share. ProShares Ultra MSCI Brazil Capped pays -- of its earnings as a dividend. Direxion Daily Pharmaceutical & Medical Bl 3X Shs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UBR or PILL?
ProShares Ultra MSCI Brazil Capped quarterly revenues are --, which are smaller than Direxion Daily Pharmaceutical & Medical Bl 3X Shs quarterly revenues of --. ProShares Ultra MSCI Brazil Capped's net income of -- is lower than Direxion Daily Pharmaceutical & Medical Bl 3X Shs's net income of --. Notably, ProShares Ultra MSCI Brazil Capped's price-to-earnings ratio is -- while Direxion Daily Pharmaceutical & Medical Bl 3X Shs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra MSCI Brazil Capped is -- versus -- for Direxion Daily Pharmaceutical & Medical Bl 3X Shs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UBRProShares Ultra MSCI Brazil Capped-- -- -- -- PILLDirexion Daily Pharmaceutical & Medical Bl 3X Shs-- -- -- --
-
Which has Higher Returns UBR or UGE?
ProShares Ultra Consumer Staples has a net margin of -- compared to ProShares Ultra MSCI Brazil Capped's net margin of --. ProShares Ultra MSCI Brazil Capped's return on equity of -- beat ProShares Ultra Consumer Staples's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UBRProShares Ultra MSCI Brazil Capped-- -- -- UGEProShares Ultra Consumer Staples-- -- -- -
What do Analysts Say About UBR or UGE?
ProShares Ultra MSCI Brazil Capped has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Consumer Staples has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra MSCI Brazil Capped has higher upside potential than ProShares Ultra Consumer Staples, analysts believe ProShares Ultra MSCI Brazil Capped is more attractive than ProShares Ultra Consumer Staples.
Company Buy Ratings Hold Ratings Sell Ratings UBRProShares Ultra MSCI Brazil Capped0 0 0 UGEProShares Ultra Consumer Staples0 0 0 -
Is UBR or UGE More Risky?
ProShares Ultra MSCI Brazil Capped has a beta of 1.704, which suggesting that the stock is 70.366% more volatile than S&P 500. In comparison ProShares Ultra Consumer Staples has a beta of 1.658, suggesting its more volatile than the S&P 500 by 65.8%.
-
Which is a Better Dividend Stock UBR or UGE?
ProShares Ultra MSCI Brazil Capped has a quarterly dividend of $0.16 per share corresponding to a yield of 4.87%. ProShares Ultra Consumer Staples offers a yield of 1.88% to investors and pays a quarterly dividend of $0.12 per share. ProShares Ultra MSCI Brazil Capped pays -- of its earnings as a dividend. ProShares Ultra Consumer Staples pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UBR or UGE?
ProShares Ultra MSCI Brazil Capped quarterly revenues are --, which are smaller than ProShares Ultra Consumer Staples quarterly revenues of --. ProShares Ultra MSCI Brazil Capped's net income of -- is lower than ProShares Ultra Consumer Staples's net income of --. Notably, ProShares Ultra MSCI Brazil Capped's price-to-earnings ratio is -- while ProShares Ultra Consumer Staples's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra MSCI Brazil Capped is -- versus -- for ProShares Ultra Consumer Staples. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UBRProShares Ultra MSCI Brazil Capped-- -- -- -- UGEProShares Ultra Consumer Staples-- -- -- --
-
Which has Higher Returns UBR or UPV?
ProShares Ultra FTSE Europe has a net margin of -- compared to ProShares Ultra MSCI Brazil Capped's net margin of --. ProShares Ultra MSCI Brazil Capped's return on equity of -- beat ProShares Ultra FTSE Europe's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UBRProShares Ultra MSCI Brazil Capped-- -- -- UPVProShares Ultra FTSE Europe-- -- -- -
What do Analysts Say About UBR or UPV?
ProShares Ultra MSCI Brazil Capped has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra FTSE Europe has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra MSCI Brazil Capped has higher upside potential than ProShares Ultra FTSE Europe, analysts believe ProShares Ultra MSCI Brazil Capped is more attractive than ProShares Ultra FTSE Europe.
Company Buy Ratings Hold Ratings Sell Ratings UBRProShares Ultra MSCI Brazil Capped0 0 0 UPVProShares Ultra FTSE Europe0 0 0 -
Is UBR or UPV More Risky?
ProShares Ultra MSCI Brazil Capped has a beta of 1.704, which suggesting that the stock is 70.366% more volatile than S&P 500. In comparison ProShares Ultra FTSE Europe has a beta of 1.865, suggesting its more volatile than the S&P 500 by 86.534%.
-
Which is a Better Dividend Stock UBR or UPV?
ProShares Ultra MSCI Brazil Capped has a quarterly dividend of $0.16 per share corresponding to a yield of 4.87%. ProShares Ultra FTSE Europe offers a yield of 1.79% to investors and pays a quarterly dividend of $0.34 per share. ProShares Ultra MSCI Brazil Capped pays -- of its earnings as a dividend. ProShares Ultra FTSE Europe pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UBR or UPV?
ProShares Ultra MSCI Brazil Capped quarterly revenues are --, which are smaller than ProShares Ultra FTSE Europe quarterly revenues of --. ProShares Ultra MSCI Brazil Capped's net income of -- is lower than ProShares Ultra FTSE Europe's net income of --. Notably, ProShares Ultra MSCI Brazil Capped's price-to-earnings ratio is -- while ProShares Ultra FTSE Europe's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra MSCI Brazil Capped is -- versus -- for ProShares Ultra FTSE Europe. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UBRProShares Ultra MSCI Brazil Capped-- -- -- -- UPVProShares Ultra FTSE Europe-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.88% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is down 0.36% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 5.95% over the past day.
